Triple Targeting of HER Receptors Overcomes Heregulin-mediated Resistance to EGFR Blockade in Colorectal Cancer

Rau, Alexander; Janssen, Nicole; Kuehl, Lennart; Sell, Thomas; Kalmykova, Svetlana; Muerdter, Thomas E.; Dahlke, Marc-H; Sers, Christine; Morkel, Markus; Schwab, Matthias; Kontermann, Roland E.; Olayioye, Monilola A.

dc.contributor.author	Janssen, Nicole
dc.contributor.author	Schwab, Matthias
dc.contributor.author	Mürdter, Thomas E.
dc.date.accessioned	2023-02-01T10:17:58Z
dc.date.available	2023-02-01T10:17:58Z
dc.date.issued	2022
dc.identifier.issn	1535-7163
dc.identifier.uri	http://hdl.handle.net/10900/135863
dc.language.iso	en	de_DE
dc.publisher	Amer Assoc Cancer Research	de_DE
dc.relation.uri	http://dx.doi.org/10.1158/1535-7163.MCT-21-0818	de_DE
dc.subject.ddc	610	de_DE
dc.title	Triple Targeting of HER Receptors Overcomes Heregulin-mediated Resistance to EGFR Blockade in Colorectal Cancer	de_DE
dc.type	Article	de_DE
utue.quellen.id	20220728000000_00973
utue.publikation.seiten	799-809	de_DE
utue.personen.roh	Rau, Alexander
utue.personen.roh	Janssen, Nicole
utue.personen.roh	Kuehl, Lennart
utue.personen.roh	Sell, Thomas
utue.personen.roh	Kalmykova, Svetlana
utue.personen.roh	Muerdter, Thomas E.
utue.personen.roh	Dahlke, Marc-H
utue.personen.roh	Sers, Christine
utue.personen.roh	Morkel, Markus
utue.personen.roh	Schwab, Matthias
utue.personen.roh	Kontermann, Roland E.
utue.personen.roh	Olayioye, Monilola A.
dcterms.isPartOf.ZSTitelID	Molecular Cancer Therapeutics	de_DE
dcterms.isPartOf.ZS-Issue	5	de_DE
dcterms.isPartOf.ZS-Volume	21	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE
utue.fakultaet	07 Mathematisch-Naturwissenschaftliche Fakultät	de_DE